Need help?

Profitable Specialty Pharmaceuticals Company Investment Opportunity in Bangalore, India

Company with 170 pharma and R&D alliances that provides clinical trials and molecular innovations.

Established 1-5 year(s)
Employees 10 - 50
Legal Entity Private Limited Company
Reported Sales USD 380 thousand
Run Rate Sales USD 760 thousand
EBITDA Margin 40 %
Industries Specialty Pharmaceuticals
Locations  Bangalore
Local Time 5:42 PM Asia / Kolkata
Listed By Business Owner / Director
Status Moderately Active
Overall Rating
Seeking Investment
USD 1.3 million for 50.0% stake (Native Currency: INR 100,000,000)
Reason: We are seeking investment to expand our global footprint.
Includes physical assets worth USD 130 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview

- We are a global speciality contract research organization (CRO) headquartered in India.

- Operate mainly in India, Europe, and the Middle East. We support our clients through pharma drug development and clinical trials.

- Our company directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe, N. America and South Korea.

- We are a quality leader in our industry and focus on the therapeutic areas of immunology, respiratory and allergy, endocrinology, oncology, GI, and CNS based on experience and expertise.

- We have 170 pharma and R&D companies who are our clients.

- Our customers are mainly from pharma, R&D, manufacturing, fertilizers, seeds, pesticides, and diagnostics.

- Company focuses on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics, and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, and rheumatology. These include, but are not limited to, small molecules, recombinant proteins, monoclonal antibodies (mAbs), drug-delivery devices, and diagnostics in oncology and immunology.

- Due to Covid we saw an increase in the demand for our services. This is the reason for the high growth rate of our sales.

Products & Services Overview

Our business model encompasses global access / early access programs, named patient programs, and securing product registrations for exclusive commercial distribution in South Asia.

Assets Overview

Physical assets include research and development machinery and a fully equipped research lab in Mysore.

Intangible assets include intellectual approvals and patents.

Facilities Overview

We have rented offices in Bangalore of area 1,200 sq feet, a lab in Mysore of area 2,500 sq feet, and an office in the Netherlands of area 1,200 sq feet.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

4 Investors already contacted this Business.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more